Insider Purchase: John Sheehan Purchased 322 Shares of Terex (TEX); Natus Medical (BABY) Shorts Lowered By 13.39%

Natus Medical Incorporated (NASDAQ:BABY) had a decrease of 13.39% in short interest. BABY’s SI was 1.70 million shares in March as released by FINRA. Its down 13.39% from 1.96M shares previously. With 635,300 avg volume, 3 days are for Natus Medical Incorporated (NASDAQ:BABY)’s short sellers to cover BABY’s short positions. The SI to Natus Medical Incorporated’s float is 5.46%. The stock increased 1.87% or $0.6 during the last trading session, reaching $32.6. About 281,749 shares traded. Natus Medical Incorporated (NASDAQ:BABY) has risen 4.38% since March 11, 2017 and is uptrending. It has underperformed by 12.32% the S&P500.

The Senior Vice President – CFO of Terex Corp, John Sheehan is in the stock market news today. It was exposed in a public form filled by John Sheehan and submitted to the Security and Exchange Commission on 09-03-2018, he bought 322 shares from the public company valued at $12,500 U.S Dollars. The insider shares average price was $38.8. It seems he is very active lately as in the last month, he silently purchased additional 292 shares of the company, worth $12,509 USD. John Sheehan presently has rights to 0.14% of the Company’s total market cap with ownership of 116,806 shares. 

Investors sentiment increased to 0.91 in 2017 Q3. Its up 0.28, from 0.63 in 2017Q2. It increased, as 19 investors sold Terex Corporation shares while 115 reduced holdings. 43 funds opened positions while 42 raised stakes. 79.42 million shares or 6.42% less from 84.87 million shares in 2017Q2 were reported. Millennium Management accumulated 285,857 shares or 0.02% of the stock. Us Comml Bank De holds 0% or 4,547 shares in its portfolio. Advisory Svcs Networks Ltd Liability Corporation holds 500 shares. Point72 Asset Mgmt Ltd Partnership holds 0.02% or 100,000 shares in its portfolio. Canada Pension Plan Investment Board has invested 0.01% in Terex Corporation (NYSE:TEX). Hutchin Hill Cap Limited Partnership accumulated 10,400 shares or 0.02% of the stock. Mirador Cap Prtn Ltd Partnership holds 0.25% of its portfolio in Terex Corporation (NYSE:TEX) for 9,343 shares. Retirement System Of Alabama holds 109,584 shares or 0.03% of its portfolio. Weaver C Barksdale & Assocs invested 0.03% of its portfolio in Terex Corporation (NYSE:TEX). Voloridge Investment Management Ltd Liability holds 0.25% of its portfolio in Terex Corporation (NYSE:TEX) for 251,113 shares. Federated Incorporated Pa has 41,246 shares for 0.01% of their portfolio. Reilly Finance Advisors Limited Company holds 0% of its portfolio in Terex Corporation (NYSE:TEX) for 728 shares. Minnesota-based Advantus Capital has invested 0.01% in Terex Corporation (NYSE:TEX). Alpha Windward Ltd holds 0.35% in Terex Corporation (NYSE:TEX) or 12,772 shares. Amalgamated Bankshares, a New York-based fund reported 15,781 shares.

The stock increased 2.96% or $1.18 during the last trading session, reaching $41.06. About 1.99M shares traded or 36.62% up from the average. Terex Corporation (NYSE:TEX) has risen 32.26% since March 11, 2017 and is uptrending. It has outperformed by 15.56% the S&P500.

Since September 11, 2017, it had 4 insider buys, and 5 selling transactions for $2.10 million activity. 10,000 shares were sold by COHEN ERIC I, worth $450,000 on Friday, September 29. Another trade for 263 shares valued at $12,482 was bought by SHEEHAN JOHN D. Another trade for 4,880 shares valued at $195,200 was sold by Clair Mark I. Another trade for 15,115 shares valued at $653,421 was sold by Hegarty Kieran. Shares for $2,298 were bought by HENRY BRIAN J. BARR KEVIN A sold 2,682 shares worth $115,453. 8,984 shares valued at $388,828 were sold by FILIPOV STEVE on Tuesday, February 27.

Terex Corporation manufactures and sells lifting and material processing products worldwide. The company has market cap of $3.33 billion. The firm operates through three divisions: Aerial Work Platforms , Cranes, and Materials Processing (MP). It has a 30.32 P/E ratio. The AWP segment designs, makes, services, and markets aerial work platform equipment, telehandlers, and light towers, as well as related components and replacement parts under the Terex and Genie brand names.

Among 21 analysts covering Terex Corporation (NYSE:TEX), 5 have Buy rating, 2 Sell and 14 Hold. Therefore 24% are positive. Terex Corporation has $59 highest and $15 lowest target. $44.38’s average target is 8.09% above currents $41.06 stock price. Terex Corporation had 82 analyst reports since July 22, 2015 according to SRatingsIntel. RBC Capital Markets maintained it with “Hold” rating and $3300 target in Monday, July 10 report. The firm earned “Hold” rating on Tuesday, September 5 by Jefferies. The stock of Terex Corporation (NYSE:TEX) has “Equal-Weight” rating given on Friday, September 25 by Barclays Capital. Bank of America downgraded Terex Corporation (NYSE:TEX) on Friday, April 28 to “Neutral” rating. The firm has “Neutral” rating by UBS given on Friday, August 26. The stock has “Buy” rating by Bank of America on Friday, October 14. Deutsche Bank initiated Terex Corporation (NYSE:TEX) rating on Wednesday, September 7. Deutsche Bank has “Hold” rating and $26 target. The firm has “Buy” rating given on Monday, October 16 by Wells Fargo. The company was maintained on Sunday, August 20 by BMO Capital Markets. The stock of Terex Corporation (NYSE:TEX) has “Hold” rating given on Tuesday, July 18 by BMO Capital Markets.

Analysts await Terex Corporation (NYSE:TEX) to report earnings on May, 1. They expect $0.36 earnings per share, up 620.00% or $0.31 from last year’s $0.05 per share. TEX’s profit will be $29.16M for 28.51 P/E if the $0.36 EPS becomes a reality. After $0.33 actual earnings per share reported by Terex Corporation for the previous quarter, Wall Street now forecasts 9.09% EPS growth.

Natus Medical Incorporated provides newborn care and neurology healthcare services and products worldwide. The company has market cap of $998.98 million. It offers services and products used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. It currently has negative earnings. The companyÂ’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories.

Since September 14, 2017, it had 0 buys, and 2 insider sales for $281,448 activity. Shares for $154,748 were sold by GUNST ROBERT A on Thursday, September 14. 4,000 shares valued at $126,700 were sold by LUDLUM KEN on Friday, March 2.